Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Cytokinetics, Incorporated CYTK NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
51/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$92.27
+41.2%

There have been 50 recent insider transactions recorded for Cytokinetics, Incorporated (CYTK), including 16 buys and 34 sells. Total insider buying was valued at $1.06M and total insider selling at $9M.

Notable insiders with recent activity include Blum Robert I, Callos Andrew, Malik Fady Ibraham. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — CYTK

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-04-01 Blum Robert I President & CEO Informative Sell 7,500 $66.63 $499.73K 422,830
2026-03-31 Callos Andrew EVP, Chief Commercial Officer Informative Sell 3,639 $65.00 $236.54K 66,004
2026-03-18 Callos Andrew EVP, Chief Commercial Officer Informative Sell 1,930 $62.07 $119.8K 78,185
2026-03-17 Blum Robert I President & CEO Informative Sell 23,928 $62.15 $1.49M 430,330
2026-03-17 Malik Fady Ibraham EVP Research & Development Informative Sell 4,397 $62.15 $273.27K 153,902
2026-03-17 Lee Sung EVP, Chief Financial Officer Informative Sell 4,935 $62.15 $306.71K 87,127
2026-03-17 Callos Andrew EVP, Chief Commercial Officer Informative Sell 2,916 $62.15 $181.23K 71,573
2026-03-16 Callos Andrew EVP, Chief Commercial Officer Informative Sell 1,709 $61.03 $104.3K 46,149
2026-03-15 Blum Robert I President & CEO RSU Award 1,665 $60.06 $100K 1,665
2026-03-15 Malik Fady Ibraham EVP Research & Development RSU Award 1,665 $60.06 $100K 1,665
2026-03-15 Hessekiel Jeffrey Chief Legal & Admin Officer RSU Award 8,325 $60.06 $500K 8,325
2026-03-15 Lee Sung EVP, Chief Financial Officer RSU Award 1,665 $60.06 $100K 1,665
2026-03-15 Callos Andrew EVP, Chief Commercial Officer RSU Award 1,665 $60.06 $100K 1,665
2026-03-09 Blum Robert I President & CEO Informative Sell 7,931 $60.72 $481.57K 391,673
2026-03-09 Malik Fady Ibraham EVP Research & Development Informative Sell 2,907 $60.72 $176.51K 138,629
2026-03-09 Callos Andrew EVP, Chief Commercial Officer Informative Sell 2,582 $60.72 $156.78K 47,858
2026-03-05 Callos Andrew EVP, Chief Commercial Officer Option Exercise (Sell) 11,000 $39.13 $430.43K 24,403
2026-03-02 Parshall B Lynne Director Informative Sell 5,000 $61.21 $306.05K 17,933
2026-03-02 Callos Andrew EVP, Chief Commercial Officer Option Exercise (Sell) 886 $37.63 $33.34K -
2026-02-05 Callos Andrew EVP, Chief Commercial Officer Informative Sell 15,000 $61.93 $928.95K 50,440
2026-02-02 Callos Andrew EVP, Chief Commercial Officer Option Exercise (Sell) 886 $37.63 $33.34K 886
2026-01-15 Henderson John T Director RSU Award 334 $63.44 $21.19K 74,912
2026-01-15 Wierenga Wendell Director RSU Award 98 $63.44 $6.22K 32,542
2026-01-15 Wysenski Nancy Director RSU Award 98 $63.44 $6.22K 30,971
2026-01-15 Kaye Edward M. Md Director RSU Award 197 $63.44 $12.5K 10,174
2026-01-15 Harrington Robert Arthur Director RSU Award 197 $63.44 $12.5K 18,739
2026-01-15 Daly James M Director RSU Award 197 $63.44 $12.5K 197
2026-01-05 Callos Andrew EVP, Chief Commercial Officer Informative Sell 15,000 $60.28 $904.2K 50,440
2026-01-02 Callos Andrew EVP, Chief Commercial Officer Option Exercise (Sell) 885 $37.63 $33.3K 1,772
2025-12-29 Callos Andrew EVP, Chief Commercial Officer Informative Sell 1,809 $62.44 $112.95K 51,353
2025-12-22 Wierenga Wendell Director Option Exercise (Sell) 20,000 $7.61 $152.2K -
2025-12-22 Blum Robert I President & CEO Option Exercise (Sell) 16,506 $6.67 $110.1K -
2025-12-22 Blum Robert I President & CEO RSU Award 5,765 - - 396,774
2025-12-22 Malik Fady Ibraham EVP Research & Development RSU Award 2,000 - - 140,552
2025-12-22 Lee Sung EVP, Chief Financial Officer RSU Award 2,152 - - 70,069
2025-12-22 Callos Andrew EVP, Chief Commercial Officer RSU Award 1,589 - - 52,249
2025-12-16 Malik Fady Ibraham EVP Research & Development Option Exercise (Sell) 2,200 $10.60 $23.32K -
2025-12-08 Callos Andrew EVP, Chief Commercial Officer Option Exercise (Sell) 1,042 $39.13 $40.77K 35,403
2025-12-05 Callos Andrew EVP, Chief Commercial Officer Option Exercise (Sell) 10,628 $37.63 $399.93K 2,657
2025-12-03 Blum Robert I President & CEO Tax Withholding of RSU 5,930 $65.02 $385.57K 350,202
2025-12-03 Malik Fady Ibraham EVP Research & Development Tax Withholding of RSU 2,058 $65.02 $133.81K 138,552
2025-12-03 Lee Sung EVP, Chief Financial Officer Tax Withholding of RSU 1,560 $65.02 $101.43K 67,917
2025-12-03 Callos Andrew EVP, Chief Commercial Officer Tax Withholding of RSU 1,368 $65.02 $88.95K 50,660
2025-12-02 Henderson John T Director Option Exercise 8,750 $10.00 $87.5K 83,328
2025-06-17 Malik Fady Ibraham EVP Research & Development Option Exercise (Sell) 2,000 $10.60 $21.2K 17,105
2025-06-16 Blum Robert I President & CEO Informative Sell 5,000 $33.80 $169K 403,108
2025-06-05 Kaye Edward M. Md Director Informative Sell 3,636 $32.10 $116.72K 29,658
2025-06-05 Callos Andrew EVP, Chief Commercial Officer Informative Sell 8,659 $32.04 $277.43K 52,028
2025-06-03 Malik Fady Ibraham EVP Research & Development Option Exercise (Sell) 2,000 $10.60 $21.2K 19,105
2025-06-02 Blum Robert I President & CEO Informative Sell 5,000 $31.22 $156.1K 408,108
■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry

People Also View

RVMD
RVMD
Revolution Medicines, Inc.
$152.54
+3.76%
 KRTX
KRTX
Karuna Therapeutics, Inc.
$329.83
+0.03%
 BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
 TERN
TERN
Terns Pharmaceuticals, Inc.
$52.71
+0.06%
 EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.70
+1.63%
 DYN
DYN
Dyne Therapeutics, Inc.
$19.98
+0.86%
 RLAY
RLAY
Relay Therapeutics, Inc.
$15.49
+5.02%
 DICE
DICE
DICE Therapeutics, Inc.
$47.55
+0.06%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message